Clinical research design > 통합검색

통합검색

한빛사

내가 찾은 검색어

1Clinical research design

'Clinical research design' 에 대한 통합검색결과 175건입니다.

한빛사175건

최신순
관련도순

- 부성현(가톨릭대학교 의과대학, 의정부성모병원)
  Interview
- 안효석(가톨릭대학교 의과대학, 의정부성모병원)
Empagliflozin and Dapagliflozin Outcomes in Heart Failure
- JAMA Netw. Open Dec 01 2025, 8 (12) | https://doi.org/10.1001/jamanetworkopen.2025.46865
- 2025.12
- 의약학
Association of maternal pre-existing atherosclerotic cardiovascular disease and neonatal and long-term offspring outcomes: a nationwide mother-child p
- Hum. Reprod. Open 25 November 2025 | https://doi.org/10.1093/hropen/hoaf074
- 2025.11
- 의약학
박미현

Technical University of Munich

Mass Spectrometry Imaging (MSI) encompasses a group of powerful imaging techniques that enable researchers to visualize the spatial distribution of hundreds of biomolecules directly within biological samples using mass spectrometry (MS). Unlike traditional bulk omics methods that average molecular signals and lose spatial information, MSI preserves the native tissue context by scanning the sample surface with an ionization source and recording a mass spectrum at each position.
- ACS Central Sci.
- 2025.11.12
- 박미현(Technical University of Munich)
  Interview
A Small Molecule Drug-Based Ru(II) Polypyridine Mass-Tag for Multimodal Imaging of Tissue Samples
- ACS Central Sci. October 21, 2025 | https://doi.org/10.1021/acscentsci.5c01381
- 2025.10
- 의약학
- 허윤석(인하대학교)
Advances in engineering immune?tumor microenvironments on-a-chip: integrative microfluidic platforms for immunotherapy and drug discovery
- Mol. Cancer 28 October 2025;24,271(2025) | https://doi.org/10.1186/s12943-025-02479-4
- 2025.10
- 생명과학
- Wubshet Mekonnen Girma(중앙대학교, Wollo University)
- 방명걸(중앙대학교)
Carbon dot-based nanohybrids for tumor microenvironment-activated cancer theranostics
- Coord. Chem. Rev. Available online 8 October 2025 | https://doi.org/10.1016/j.ccr.2025.217236
- 2025.10
- 의약학
- 김민서(Broad Institute of MIT and Harvard/Massachusetts General Hospital)
Contributions of Common, Rare, and Somatic Genetic Variants to Incidence of Atrial Fibrillation
- JAMA Cardiol. Oct 08 2025, e253664 | https://doi.org/10.1001/jamacardio.2025.3664
- 2025.10
- 김유진(고려대학교)
- 김종승(고려대학교)
Activatable small-molecule NIR fluorescent/photoacoustic probes for brain disease imaging
- Coord. Chem. Rev. 4 September 2025 | https://doi.org/10.1016/j.ccr.2025.217149
- 2025.09
- 전주은(Massachusetts General Hospital / Harvard Medical School)
- 이학호(Massachusetts General Hospital / Harvard Medical School)
Computationally Designed Nanobinders as Affinity Ligands in Diagnostic and Therapeutic Applications
- J. Am. Chem. Soc. Aug 21 2025, | https://doi.org/10.1021/jacs.5c11289
- 2025.08
- 바이오·의료융합
- 노윤하(전남대학교 약학대학)
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes
- Ann. Intern. Med. 2025 Jul 15 | https://doi.org/10.7326/ANNALS-24-03420
- 2025.07
- 의약학
Niti Sharma

가천대학교

Recent cerebrospinal fluid (CSF) proteomic research categorized AD into five molecular subtypes with discrete genetic risk profiles. Subtypes 1-3, namely neuronal hyperplasticity, innate immune activation, and RNA dysregulation, were characterized by more classical AD-related changes, like accumulation of amyloid/tau, and synaptic and immune dysfunction.
- Alzheimers. Dement.
- 2025.07.31
A Multimodal Predictive Model for Chronic Kidney Disease and Its Association With Vascular Complications in Patients With Type 2 Diabetes: Model Devel
- Diabetes Care Jul 01 2025, dc250355 | https://doi.org/10.2337/dc25-0355
- 2025.07
- 바이오·의료융합
Intelligent soft wearable bioelectronics for neurological disorders
- Mater. Horizons Jun 16 2025, | https://doi.org/10.1039/d5mh00528k
- 2025.06
- 바이오·의료융합
- 강유미(Brigham and Women's Hospital and Harvard Medical School)
  Interview
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial
- Diabetes Care Jun 22 2025, dc250942 | https://doi.org/10.2337/dc25-0942
- 2025.06
- 의약학
Deescalation From Ticagrelor to Clopidogrel for Myocardial Infarction With Chronic Kidney Disease: A Secondary Analysis of a Randomized Clinical Trial
- JAMA Netw. Open May 01 2025, 8 (5) | https://doi.org/10.1001/jamanetworkopen.2025.11297
- 2025.05
- 의약학
- 백민준(Massachusetts General Hospital and Harvard Medical School, 현 KAIST)
- 최학수(Massachusetts General Hospital and Harvard Medical School)
Design Considerations for Organ-Selective Nanoparticles
- ACS Nano Apr 22 2025, 19 (15) | https://doi.org/10.1021/acsnano.5c00484
- 2025.04
- 바이오·의료융합
- 정영환(St. Jude Children’s Research Hospital, 현 University of Texas Medical Branch)
Decoding the selective chemical modulation of CYP3A4
- Nat. Commun. Published: 10 April 2025 | https://doi.org/10.1038/s41467-025-58749-8
- 2025.04
- 의약학
Bio-Inspired, Miniaturized Magnetic Heart Valve System for Superior Performance Cardiovascular Simulator
- Adv. Mater. Apr 2025, 37 (16) | https://doi.org/10.1002/adma.202419504
- 2025.04
- 바이오·의료융합
나타니엘 카르페나

단국대학교

Our research aimed to address a long-standing challenge in hearing loss therapy: how to generate functional cochlear hair cells in the lab. These cells are responsible for converting sound vibrations into electrical signals that the brain can interpret. In humans, once these cells are damaged-due to aging, noise, or drugs-they do not regenerate.
- Theranostics
- 2025.04.28
Sana Abdul Khaliq

가천대학교 의과대학

In this study, we investigated how a protein called ARHGEF3 regulates fat cell (adipocyte) development and enlargement?two key processes involved in obesity. We discovered that ARHGEF3 plays a dual role: it helps fat cells grow in size through the YAP-RhoA signaling pathway, and it promotes their full differentiation by boosting the activity of PPARγ, a master regulator of fat cell development.
- J. Adv. Res.
- 2025.04.26